Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time

Molecular Psychiatry

Volumn 20, Issue 5, 2015, Pages 602-608

  Bus, B A A ^a   Molendijk, M L ^b,c   Tendolkar, I ^a,d,e   Penninx, B W J H ^c,f,g   Prickaerts, J ^h   Elzinga, B M ^b,c   Voshaar, R C O ^a,g  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e RADBOUD UNIVERSITY   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ANTIDEPRESSANT AGENT;

ADULT; AGE; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; ONSET AGE; PRIORITY JOURNAL; REMISSION; SMOKING; BLOOD; CHILD; CHILD ABUSE; CHRONIC DISEASE; CLASSIFICATION; MIDDLE AGED; NONPARAMETRIC TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RETROSPECTIVE STUDY;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; CHILD ABUSE; CHRONIC DISEASE; DEPRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84929070828     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.83     Document Type: Article

References (33)

1. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-1127
2. Penninx BW, Nolen WA, Lamers F, Zitman FG, Smit JH, Spinhoven P, et al. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESD). J Affect Disord 2011; 133: 76-85
3. Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-Term treatment strategies. Arch Gen Psychiatry 2004; 61: 1097-1103
4. Kendler KS, Thornton LM, Gardner CO. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 2001; 158: 582-586
5. Robinson OJ, Sahakian BJ. Recurrence in major depressive disorder: a neurocognitive perspective. Psychol Med 2008; 38: 315-318
6. Booij SH, Bouma EM, de Jonge P, Ormel J, Oldehinkel AJ. Chronicity of depressive problems and the cortisol response to psychosocial stress in adolescents: the TRAILS study. Psychoneuroendocrinology 2013; 38: 659-666
7. Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-Analyses on 179 associations (N = 9484). Mol Psychiatry 2013; 19: 791-800
8. Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J, et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-Trait issues, clinical features and pharmacological treatment. Mol Psychiatry 2011; 11: 1088-1095
9. Yoshimura R, Hori H, Sugita-Ikenouchi A, Umene-Nakano W, Katsuki A, Nakamura J. Serum brain-derived neurotrophic factor levels at 6 months after remission are not associated with subsequent depressive episodes. J Clin Psychopharmacol 2013; 33: 142-143
10. Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P, et al. The Netherlands Study of Depression and Anxiety (NESD): rationale, objectives and methods. Int J Methods Psychiatr Res 2008; 17: 121-140
11. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996; 26: 477-486
12. Lyketsos CG, Nestadt G, Cwi J, Heithoff K, Eaton WW. The Life Chart Interview-A standardized method to describe the course of psychopathology. Int J Method Psych 1994; 4: 143-155
13. Levine DW, Kripke DF, Kaplan RM, Lewis MA, Naughton MJ, Bowen DJ, et al. Reliability and validity of the Womens Health Initiative Insomnia Rating Scale. Psychol Assess 2003; 15: 137-148
14. de Graaf R, Bijl RV, Ten Have M, Beekman AT, Vollebergh WA. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J Affect Disord 2004; 82: 461-467
15. Brugha T, Bebbington P, Tennant C, Hurry J. The List of Threatening Experiences: a subset of 12 life event categories with considerable long-Term contextual threat. Psychol Med 1985; 15: 189-194
16. Brugha TS, Cragg D. The List of Threatening Experiences: the reliability and validity of a brief life events questionnaire. Acta Psychiat Scand 1990; 82: 77-81
17. Bus BA, Molendijk ML, Penninx BJ, Buitelaar JK, Kenis G, Prickaerts J, et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011; 36: 228-239
18. Bus BA, Tendolkar I, Franke B, de GJ, Heijer MD, Buitelaar JK, et al. Serum brainderived neurotrophic factor: Determinants and relationship with depressive symptoms in a community population of middle-Aged and elderly people. World J Biol Psychiatry 2012; 13: 39-47
19. Babor TF, Kranzler HR, Lauerman RJ. Early detection of harmful alcohol consumption: comparison of clinical, laboratory, and self-report screening procedures. Addict Behav 1989; 14: 139-157
20. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-46
21. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170
22. McKinnon MC, Yucel K, Nazarov A, MacQueen GM. A meta-Analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 2009; 34: 41-54
23. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56: 131-137
24. Schmidt HD, Duman RS. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2010; 35: 2378-2391
25. Dreimuller N, Schlicht KF, Wagner S, Peetz D, Borysenko L, Hiemke C, et al. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression. Neuropharmacology 2012; 62: 264-269
26. Tadic A, Wagner S, Schlicht KF, Peetz D, Borysenko L, Dreimuller N, et al. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 415-420
27. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-Analyses and implications. Biol Psychiatry 2008; 64: 527-532
28. Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Prickaerts J, Oude Voshaar RC, et al. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety. World J Biol Psychiatry 2012; 13: 535-543
29. Pies R. Are antidepressants effective in the acute and long-Term treatment of depression? Sic et Non. Innov Clin Neurosci 2012; 9: 31-40
30. Ziegenhorn AA, Schulte-Herbruggen O, Danker-Hopfe H, Malbranc M, Hartung HD, Anders D, et al. Serum neurotrophins-A study on the time course and influencing factors in a large old age sample. Neurobiol Aging 2007; 28: 1436-1445
31. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005; 26: 115-123
32. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Low brainderived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57: 1068-1072
33. Lederbogen F, Horer E, Hellweg R, Heuser I, Deuschle M. Platelet counts in depressed patients treated with amitriptyline or paroxetine. Eur Psychiatry 2003; 18: 89-91